Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 322-331, March 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fisher, B.
Right arrow Articles by Fisher, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, B.
Right arrow Articles by Fisher, E. R.

Evaluation of a Humoral Factor in Liver Regeneration Utilizing Liver Transplants1

Bernard Fisher2, Patricia Szuch and Edwin R. Fisher

Departments of Surgery [B. F., P. S.] and Pathology [E. R. F.], University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213

Information has been obtained concerning the extracellular control of liver regeneration by transplanting, with blood vessel anastomoses, auxiliary livers into isologous rats. Partial or whole livers, vascularized one of three ways, were inserted into hosts with whole or partially hepatectomized livers in which there was either a normal blood supply or an absence of portal flow. Bile ducts of transplants were either cannulated or ligated. Hepatic parenchymal cell activity was determined by number of mitoses and incorporation of 32P into DNA.

Findings obtained from a variety of host and transplant combinations indicate the following. (a) They failed to confirm a factor, as more conventionally described by others, in hepatic regeneration. A partial (30%)-liver transplant failed to initiate a parenchymal cell response in whole host livers and, similarly, partial hepatectomy of the latter resulted in no stimulation of such cells in whole-liver transplants. An explanation for the difference in results is presented which suggests that there is a portal blood factor (PBF) which is capable of stimulating hepatic cells and that its effectiveness is inversely related to the number of liver cells present. (b) This PBF was neither destroyed nor inhibited in systemic blood, since livers in portacaval-shunted, partially hepatectomized, nontransplanted animals responded similarly to such livers in nonshunted animals. (c) The diversion of portal blood through a whole-liver transplant prior to its entry into the systemic circulation prevented such a response in the liver remnant of the host as well as in the transplant. (d) Diversion of portal blood through a partial liver transplant resulted in a response in the transplant similar to that which occurred in the remnant of a partially hepatectomized, nontransplanted animal, despite the presence of an additional whole liver (host), which failed to demonstrate stimulation. (e) When a partial liver was transplanted into a hepatectomized host and the transplant received portal blood, it responded as would a similar nontransplanted liver remnant, whereas the host liver remnant response was considerably diminished, indicating utilization of the factor by the transplant so that little was available for stimulation of the host liver. Such findings are difficult to relate to reduction of inhibitor by partial hepatectomy as a factor in regeneration. They more readily suggest that a disturbance of the "normal" relationship between the quantity of PBF available and the number of hepatic cells present results in the regenerative response. With proliferation of liver cells and restoration of the "equilibrium," regeneration ceases. Studies relative to the nature, site of origin, mechanism of action, and regulation of concentration of PBF are in progress.

1 Supported by USPHS Grants AM-13228 and AI-08206.

2 To whom reprint requests may be sent, at University of Pittsburgh, School of Medicine, Pittsburgh, Pa. 15213.

Received 8/31/70. Accepted 11/16/70.




This article has been cited by other articles:


Home page
Arch SurgHome page
J. F. Buell, A. C. Berger, J. S. Plotkin, P. C. Kuo, and L. B. Johnson
The Clinical Implications of Hypophosphatemia Following Major Hepatic Resection or Cryosurgery
Arch Surg, July 1, 1998; 133(7): 757 - 761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.